ASGCT Podcast Network American Society of Gene & Cell Therapy
-
- Science
-
The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.
-
Meet Dr. Mohamed Abou-el-Enein, Editor-in-Chief of Molecular Therapy Methods & Clinical Development | The Molecular Therapy Podcast
Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific Editor Rory Bricker-Anthony, PhD, to discuss his vision for the journal.
If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, on September 23 and 24.
This can't-miss event brings together policymakers and gene and cell therapy experts, including FDA leaders Julie Tierney and Nicole Verdun, PhD, to discuss the latest policies impacting this rapidly evolving field.
Register now at ASGCT.org/PolicySummit for invaluable insights on navigating the regulatory landscape. Virtual attendance options are also available.
Dr. Abou-el-Enein has served as MTMCD's associate editor-in-chief for the past two years, which will allow him to make a smooth transition in leadership. His vision for MTMCD is consistent innovation, evolution, and growth. Dr. Abou-el-Enein firmly believes that MTMCD has the potential to become a leading voice in the gene and cell therapy landscape. He is eager to leverage his experience and expertise to expand the journal’s reach and impact.
Dr. Abou-el-Enein is an associate professor of clinical medicine (oncology), pediatrics, and stem cell biology and regenerative medicine at USC Keck School of Medicine as well as executive director of the USC/CHLA cell therapy program. He is an internationally recognized expert in planning and executing clinical development programs, designing and operating academic GMP facilities, and translating cell and gene therapy products from preclinical research to clinical applications. His research laboratory is dedicated to pioneering advancements in CAR T-cell therapies, including optimizing engineering techniques and devising novel strategies for allogeneic applications and genetic delivery tools to increase accessibility and scalability.
'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.www.scottbuckley.com.au
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information. -
Increasing Equitable Access with Hayley Lam, PhD
At #ASGCT2024, Dr. Lam (CIRM) spoke during a symposium on developing CGTs with a DEI-forward approach. In this interview, she talks about incorporating DEI into the review criteria for CIRM's funded programs, how to measure DEI, and what she'd like to see in the long term for patients.
Meeting registrants can watch this session (and all others) through June 21 on the virtual platform and the app!
Host: Lynnea Olivarez, incoming Communications Commmittee Chair
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information. -
An Explosive Year for Gene Therapy with ASGCT President Paula Cannon
As she begins her tenure as ASGCT President, Paula Cannon, PhD (USC), tells host Lynnea Olivarez, incoming chair of the Communications Committee, why she's excited to take the reins for the Society.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information. -
Reporting on Regulatory Considerations with Journalist Jef Akst
Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information. -
CNS Gene Therapies with Todd Carter, PhD
Todd Carter, PhD (CSO at Voyager Therapeutics) talks with incoming Communications Committee Chair Lynnea Olivarez about changes in the approach to developing gene therapies for CNS disorders like Huntington's disease.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information. -
New Frontiers in Hemophilia Treatments with Lindsey George, MD
ASGCT Board of Directors member Lindsey George, MD, (Children's Hospital of Philadelphia) discusses the dramatic advancements in available treatment options for patients with hemophilia and the responsibility of scientists and clinicians in guiding patients through these once-in-a-lifetime decisions.
Host: Lynnea Olivarez, incoming chair of the ASGCT Communications Committee
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
Customer Reviews
Waiting for next episodes…
Finally a podcast for Gene therapy!! Great job.
Looking forward to upcoming episodes to learn more about this amazing field.